PACER – A multicentre, single-arm, two-stage, phase 2 study of panitumumab in patients with cetuximab-refractory metastatic colorectal cancer (mCRC)Bruno Daniele, Maria Carmela Piccirillo, Gerardo Rosati et al.|Annals of Oncology|2016Cited by 1
A multicentre, randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer (mCRC)A. Antonio, Federica Perrone, Maria Carmela Piccirillo et al.|Annals of Oncology|2016Cited by 0